PLAB 1 → Infection
Infection accounts for roughly 5% of the PLAB 1 blueprint. This bank has 118 items tagged to it.
Around 5% of the paper, per GMC Medical Licensing Assessment content map. That weighting is why the DocPasser mock builder samples sections in proportion rather than shuffling everything into one pile — practising a flat distribution trains you for a paper that does not exist.
A 27 year old man has a fever, a widespread maculopapular rash, a sore throat, mouth ulcers and tender cervical lymphadenopathy for five days. He had unprotected sex with a new partner three weeks ago. His Monospot is negative. He feels systemically unwell but is haemodynamically stable. What is the SINGLE most likely diagnosis?
The point: Offer an HIV test much more often than feels needed. Test everyone who registers with a GP or is admitted to hospital in an area where HIV is common, anyone with an indicator condition (an illness that is much more common with HIV and should make you test for it), and anyone who asks for one. The standard test looks for both a piece of the virus and the body's antibody to it (a fourth-generation antigen-antibody test), and it can find infection from about four weeks. After one known exposure, repeat it at twelve weeks to rule the infection out for good. Seroconversion (the short illness the body has when it first meets the virus) looks like glandular fever, with fever, a rash, a sore throat and swollen glands (lymphadenopathy). This is the point where the diagnosis is missed most often, because it looks like an ordinary viral illness. Start treatment (antiretroviral therapy) in everyone, whatever the CD4 count (the blood test that shows how many defence cells are left). The CD4 count then sets the risk of an opportunistic infection (an infection that only takes hold because the immune system is weak): Pneumocystis pneumonia below a CD4 of 200, which is also the point to start preventive antibiotics, and cerebral toxoplasmosis (a brain infection) and cryptococcal disease (a fungal infection) at an even lower count. Give post-exposure prophylaxis (medicine to stop the virus taking hold after a likely exposure) within 72 hours, and offer pre-exposure prophylaxis (medicine taken beforehand to prevent infection) to people at ongoing risk. The choice to test belongs to the patient alone, and the result stays private.
Source: BHIVA — Guidelines for the routine investigation and monitoring of adult HIV-1-positive individuals British HIV Association · tier 2, specialty society or college
A 27 year old man has a fever, a widespread maculopapular rash, a sore throat, mouth ulcers and tender cervical lymphadenopathy for five days. He had unprotected sex with a new partner three weeks ago. His Monospot is negative. He feels systemically unwell but is haemodynamically stable. What is the SINGLE most appropriate initial investigation?
The point: Offer an HIV test much more often than feels needed. Test everyone who registers with a GP or is admitted to hospital in an area where HIV is common, anyone with an indicator condition (an illness that is much more common with HIV and should make you test for it), and anyone who asks for one. The standard test looks for both a piece of the virus and the body's antibody to it (a fourth-generation antigen-antibody test), and it can find infection from about four weeks. After one known exposure, repeat it at twelve weeks to rule the infection out for good. Seroconversion (the short illness the body has when it first meets the virus) looks like glandular fever, with fever, a rash, a sore throat and swollen glands (lymphadenopathy). This is the point where the diagnosis is missed most often, because it looks like an ordinary viral illness. Start treatment (antiretroviral therapy) in everyone, whatever the CD4 count (the blood test that shows how many defence cells are left). The CD4 count then sets the risk of an opportunistic infection (an infection that only takes hold because the immune system is weak): Pneumocystis pneumonia below a CD4 of 200, which is also the point to start preventive antibiotics, and cerebral toxoplasmosis (a brain infection) and cryptococcal disease (a fungal infection) at an even lower count. Give post-exposure prophylaxis (medicine to stop the virus taking hold after a likely exposure) within 72 hours, and offer pre-exposure prophylaxis (medicine taken beforehand to prevent infection) to people at ongoing risk. The choice to test belongs to the patient alone, and the result stays private.
Source: BHIVA — Guidelines for the routine investigation and monitoring of adult HIV-1-positive individuals British HIV Association · tier 2, specialty society or college
A 27 year old man has a fever, a widespread maculopapular rash, a sore throat, mouth ulcers and tender cervical lymphadenopathy for five days. He had unprotected sex with a new partner three weeks ago. His Monospot is negative. He feels systemically unwell but is haemodynamically stable. What is the SINGLE most appropriate immediate management?
The point: Offer an HIV test much more often than feels needed. Test everyone who registers with a GP or is admitted to hospital in an area where HIV is common, anyone with an indicator condition (an illness that is much more common with HIV and should make you test for it), and anyone who asks for one. The standard test looks for both a piece of the virus and the body's antibody to it (a fourth-generation antigen-antibody test), and it can find infection from about four weeks. After one known exposure, repeat it at twelve weeks to rule the infection out for good. Seroconversion (the short illness the body has when it first meets the virus) looks like glandular fever, with fever, a rash, a sore throat and swollen glands (lymphadenopathy). This is the point where the diagnosis is missed most often, because it looks like an ordinary viral illness. Start treatment (antiretroviral therapy) in everyone, whatever the CD4 count (the blood test that shows how many defence cells are left). The CD4 count then sets the risk of an opportunistic infection (an infection that only takes hold because the immune system is weak): Pneumocystis pneumonia below a CD4 of 200, which is also the point to start preventive antibiotics, and cerebral toxoplasmosis (a brain infection) and cryptococcal disease (a fungal infection) at an even lower count. Give post-exposure prophylaxis (medicine to stop the virus taking hold after a likely exposure) within 72 hours, and offer pre-exposure prophylaxis (medicine taken beforehand to prevent infection) to people at ongoing risk. The choice to test belongs to the patient alone, and the result stays private.
Source: BHIVA — Guidelines for the routine investigation and monitoring of adult HIV-1-positive individuals British HIV Association · tier 2, specialty society or college
Acute and emergency · Cancer · Cardiovascular · Child health · Clinical haematology · Clinical imaging · Dermatology · Ear, nose and throat · Endocrine, diabetes and metabolic · Gastrointestinal · General practice and primary healthcare · Medicine of the older adult · Mental health · Musculoskeletal · Neurosciences · Obstetrics and gynaecology · Ophthalmology · Palliative and end of life care · Perioperative medicine and anaesthesia · Renal and urology · Respiratory · Sexual health · Surgery